We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SCYX market cap is 41.74M. The company's latest EPS is USD 1.7666 and P/E is 0.63.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.76M | 5.8M | 1.37M | 736k | 660k |
| Operating Income | -10.1M | -23.07M | -9.51M | -9.24M | -10.32M |
| Net Income | -1.76M | -19.59M | 411k | -14.46M | -2.81M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 121k | 0 | 13.16M | 5.09M | 140.14M |
| Operating Income | -48.92M | -51.15M | -60.84M | -85.76M | 72.67M |
| Net Income | -53.71M | -55.19M | -32.87M | -62.81M | 67.04M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 148.55M | 128.41M | 118.25M | 107.81M | 99.04M |
| Total Liabilities | 56.56M | 55.45M | 44.15M | 47.4M | 40.51M |
| Total Equity | 91.99M | 72.96M | 74.11M | 60.41M | 58.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 57.15M | 102.54M | 119.84M | 87.81M | 128.41M |
| Total Liabilities | 44.26M | 79.78M | 78.58M | 84.58M | 55.45M |
| Total Equity | 12.9M | 22.76M | 41.26M | 3.23M | 72.96M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 67.89M | 60.16M | -4.01M | -14.87M | -14.1M |
| Investing | -32.73M | -34.88M | 5.45M | 6.83M | 8.77M |
| Financing | -36.59M | -36.72M | -15k | -15k | 16k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -38.12M | -49.35M | -54.56M | -79.88M | 60.16M |
| Investing | 26.24M | 6.47M | -1.17M | -27.39M | -34.88M |
| Financing | 42.31M | 94M | 67.12M | 48.6M | -36.72M |
| Market Cap | 41.74M |
| Price to Earnings Ratio | 0.63 |
| Price to Sales Ratio | 0.3 |
| Price to Cash Ratio | 1.25 |
| Price to Book Ratio | 0.58 |
| Dividend Yield | - |
| Shares Outstanding | 37.95M |
| Average Volume (1 week) | 197.97k |
| Average Volume (1 Month) | 325.47k |
| 52 Week Change | -41.18% |
| 52 Week High | 3.07 |
| 52 Week Low | 0.9006 |
| Spread (Intraday) | 0.04 (3.48%) |
| Company Name | Scynexis Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.scynexis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
